Clinical Trial Update: Dose-dense Capecitabine Schedule [7days on _7 Days Off] in Colorectal Cancer in Comparison With Standered Regimen [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating a dose-dense capecitabine schedule (7 days on, 7 days off) in colorectal cancer, compared with the standard regimen.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)

Snippet

Sponsor: Sohag University | Conditions: Colorectal Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING